[1]张启珍,罗顺利,王勤.TSCPC联合改良小梁切除术治疗新生血管性青光眼的临床疗效观察[J].眼科新进展,2014,34(8):784-786.[doi:10.13389/j.cnki.rao.2014.0217]
　ZHANG Qi-Zhen,LUO Shun-Li,WANG Qin.Clinical study of improved trabeculectomy combined with TSCPC for neovascular glaucoma[J].Recent Advances in Ophthalmology,2014,34(8):784-786.[doi:10.13389/j.cnki.rao.2014.0217]
点击复制

TSCPC联合改良小梁切除术治疗新生血管性青光眼的临床疗效观察
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
34卷
期数:
2014年8期
页码:
784-786
栏目:
应用研究
出版日期:
2014-08-05

文章信息/Info

Title:
Clinical study of improved trabeculectomy combined with TSCPC for neovascular glaucoma
作者:
张启珍; 罗顺利; 王勤
河南省周口市，周口市眼科医院
Author(s):
ZHANG Qi-Zhen; LUO Shun-Li; WANG Qin
关键词:
新生血管性青光眼; 半导体二极管激光经巩膜睫状体光凝术; 改良小梁切除术
Keywords:
neovascular glaucoma;  transscleral cylophotocoagulation ;  improved trabeculectomy
DOI:
10.13389/j.cnki.rao.2014.0217
文献标志码:
A
摘要:
目的　观察半导体二极管激光经巩膜睫状体光凝术（ｔｒａｎｓｓｃｌｅｒａｌｃｙｌｏｐｈｏｔｏｃｏａｇｕｌａｔｉｏｎ，ＴＳＣＰＣ）联合改良小梁切除术治疗新生血管性青光眼（ｎｅｏｖａｓｃｕｌａｒｇｌａｕｃｏｍａ，ＮＶＧ）的临床疗效。方法　选取２０１１年１月至２０１２年１２月就诊于我院的ＮＶＧ患者４６例（４６眼），均采用ＴＳＣＰＣ治疗联合改良小梁切除术，术后随访６～１２个月，观察患者术后一般疗效、视力、眼压及并发症等情况。结果　４６眼中手术完全成功３８眼，条件成功６眼，失败２眼，手术成功率为９５．７％。与术前比较，术后１周、１个月、６个月视力均有不同程度提高，差异均有统计学意义（均为Ｐ＜０．０５）。术前眼压为（３８．９±３．２）ｍｍＨｇ（１ｋＰａ＝７．５ｍｍＨｇ），术后１周、１个月、６个月眼压分别为（１８．２±１．２）ｍｍＨｇ、（１７．８±１．６）ｍｍＨｇ、（１７．２±１．５）ｍｍＨｇ，与术前比较，差异均有显著统计学意义（均为Ｐ＜０．０１）。术后１周形成功能性滤过泡３９眼（８４．８％），非功能性滤过泡７眼（１５．２％）；术后６个月形成功能性滤过泡４２眼（９１．３％），非功能性滤过泡４眼（８．７％）。术后并发症主要包括前房积血、浅前房、前部葡萄膜炎、玻璃体出血等。结论　ＴＳＣＰＣ联合改良小梁切除术能显著控制ＮＶＧ患者眼压，并发症较少。
Abstract:
Objective To evaluate the clinical effects of improved trabeculectomy combined with transscleral cylophotocoagulation ( TSCPC) for neovascular glaucoma ( NVG) . Methods Forty-six cases (46 eyes) with NVG received improved trabeculectomy combined with TSCPC , the follow-up time was from 6 months t0 12 months , the general therapeutic effect . visual acuity ,intraocular pressure and complications were observed after operation. Results In 46 eyes, the surgery was successful totally in 38 eyes,conditional successful in 6 eye,failed in 2 eyes, the successful rate was 95. 7% . Compare with pre-operation, the visual acuity at postoperative I week, I month and 6 months were increased to certain degree ( all P < 0. 05 ) . The preoperative intraocular pressure was ( 38. 9 + 3. 2) mmHg ( I kPa = 7. 5 mmHg) , the postoperative I week, I month and 6 months were ( 18. 2 + 1. 2 ) mmHg , ( 17. 8 + 1. 6) mmHg and ( 17. 2 + 1. 5 ) mmHg , respectively , there were statistical differences compared with pre-operation ( all P < 0. 01) . The functional filtering bleb were formed in 39 eyes ( 84. 8% ) and 42 eyes (91. 3% ) at postoperative I week and 6 months,the dysfunctional filtering blebs were in 7 eyes ( 15. 2% ) and 4 eyes ( 8. 7% ) , respectively. Conclusion Improved trabeculectomy combined with TSCPC for NVG can obviously control the intraocular pressure with less complication.

相似文献/References:

[1]赵宁 万超 刘宁宁 王建英 陈蕾 才娜.玻璃体切割联合超全视网膜光凝、白内障摘出术治疗新生血管性青光眼[J].眼科新进展,2012,32(6):000.
[2]代应辉 李娟 王剑锋 秦梅 高自清.前部视网膜、睫状体冷凝联合复合式小梁切除术治疗新生血管性青光眼的临床研究[J].眼科新进展,2012,32(6):000.
[3]李秀云 李聪伶 王俊 李娜 赵岩松.Avastin联合周边视网膜冷冻术治疗晚期新生血管性青光眼[J].眼科新进展,2012,32(12):000.
[4]张启珍 罗顺利 王勤.改良小梁切除术联合睫状体视网膜冷凝治疗新生血管性青光眼[J].眼科新进展,2013,33(7):000.
[5]马红利 李世洋 赵爱红 蒋骁男 陈萍.尿毒症血液透析继发新生血管性青光眼的治疗[J].眼科新进展,2012,32(8):000.
[6]田汝银 赖铭莹.Bevacizumab在新生血管性青光眼治疗中的应用[J].眼科新进展,2010,30(4):000.
[7]王俊,孟晓光,李秀云,等.Bevacizumab玻璃体内注射联合视网膜光凝及冷凝治疗新生血管性青光眼[J].眼科新进展,2014,34(6):557.[doi:10.13389/j.cnki.rao.2014.0152]
[8]何广辉,李燕.新生血管性青光眼的临床诊疗现状[J].眼科新进展,2014,34(10):997.[doi:10.13389/j.cnki.rao.2014.0277]
[9]刘斌,杨玉霞,刘杏,等. 雷珠单抗联合Ahmed青光眼阀植入术治疗新生血管性青光眼[J].眼科新进展,2015,35(3):263.[doi:10.13389/j.cnki.rao.2015.0070]
　LIU Bin,YANG Yu-Xia,LIU Xing,et al. Intravitreal lucentis injection combined with Ahmed valve implantation for neovascular glaucoma[J].Recent Advances in Ophthalmology,2015,35(8):263.[doi:10.13389/j.cnki.rao.2015.0070]
[10]张娣,张玲,杨静,等.玻璃体内注射康柏西普联合手术及全视网膜光凝治疗新生血管性青光眼[J].眼科新进展,2015,35(12):1170.[doi:10.13389/j.cnki.rao.2015.0320]
　ZHANG Di,ZHANG Ling,YANG Jing,et al.Intravitreal injection of conbercept combined with operation and panretinal photocoagulation for neovascular glaucoma[J].Recent Advances in Ophthalmology,2015,35(8):1170.[doi:10.13389/j.cnki.rao.2015.0320]
[11]刘莹 居东彬 付汛安.TSCPC和睫状体冷凝术治疗晚期新生血管性青光眼的临床研究[J].眼科新进展,2013,33(12):000.

更新日期/Last Update: 2014-07-30